Brief Statement FIGO Safe Motherhood and Newborn Health Committee 31 August 2012 FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage

First Page		Document Content
Date: 2012-09-10 09:47:55 Chemistry Abortifacients Gastroenterology Ketones Misoprostol Prostaglandins International Federation of Gynaecology and Obstetrics Oxytocin Obstetrics Medicine Gynaecology Human reproduction		Brief Statement FIGO Safe Motherhood and Newborn Health Committee 31 August 2012 FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage Add to Reading List Source URL: www.figo.org Download Document from Source Website File Size: 198,63 KB Share Document on Facebook

	Characterization of a novel vasopressin/oxytocin superfamily peptide and its receptor from an ascidian, Ciona intestinalis DocID: 1vdQb - View Document
	Characterization of a novel vasopressin/oxytocin superfamily peptide and its receptor from an ascidian, Ciona intestinalis DocID: 1uXlo - View Document
	Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted? DocID: 1upWi - View Document
	Oxytocin and the Social Brain: Beware the Complexity DocID: 1tqKd - View Document
	Hormones and Behavior – 527 www.elsevier.com/locate/yhbeh Oxytocin is associated with human trustworthiness Paul J. Zak a,b,c,*, Robert Kurzban d, William T. Matzner e a DocID: 1sftp - View Document